120 related articles for article (PubMed ID: 14981982)
21. Correspondence between flat aberrant crypt foci and mucin-depleted foci in rodent colon carcinogenesis.
Femia AP; Paulsen JE; Dolara P; Alexander J; Caderni G
Anticancer Res; 2008; 28(6A):3771-5. PubMed ID: 19189663
[TBL] [Abstract][Full Text] [Related]
22. Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon.
Shpitz B; Bomstein Y; Mekori Y; Cohen R; Kaufman Z; Grankin M; Bernheim J
Am J Surg; 1997 Oct; 174(4):425-30. PubMed ID: 9337168
[TBL] [Abstract][Full Text] [Related]
23. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer.
Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW
Cancer Res; 2004 Sep; 64(18):6394-401. PubMed ID: 15374946
[TBL] [Abstract][Full Text] [Related]
24. Effects of resistant starch on colonic preneoplastic aberrant crypt foci in rats.
Liu R; Xu G
Food Chem Toxicol; 2008 Aug; 46(8):2672-9. PubMed ID: 18571825
[TBL] [Abstract][Full Text] [Related]
25. Increased microvascular blood content is an early event in colon carcinogenesis.
Wali RK; Roy HK; Kim YL; Liu Y; Koetsier JL; Kunte DP; Goldberg MJ; Turzhitsky V; Backman V
Gut; 2005 May; 54(5):654-60. PubMed ID: 15831911
[TBL] [Abstract][Full Text] [Related]
26. Aberrant crypt foci in patients with a positive family history of sporadic colorectal cancer.
Stevens RG; Swede H; Heinen CD; Jablonski M; Grupka M; Ross B; Parente M; Tirnauer JS; Giardina C; Rajan TV; Rosenberg DW; Levine J
Cancer Lett; 2007 Apr; 248(2):262-8. PubMed ID: 16950561
[TBL] [Abstract][Full Text] [Related]
27. Significance and role of early-lesions in experimental colorectal carcinogenesis.
Mori H; Hata K; Yamada Y; Kuno T; Hara A
Chem Biol Interact; 2005 Jun; 155(1-2):1-9. PubMed ID: 15904905
[TBL] [Abstract][Full Text] [Related]
28. Endocytoscopy can identify dysplasia in aberrant crypt foci of the colorectum: a prospective in vivo study.
Cipolletta L; Bianco MA; Rotondano G; Piscopo R; Meucci C; Prisco A; Cipolletta F; de Gregorio A; Salvati A
Endoscopy; 2009 Feb; 41(2):129-32. PubMed ID: 19214891
[TBL] [Abstract][Full Text] [Related]
29. Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions.
Sena P; Saviano M; Monni S; Losi L; Roncucci L; Marzona L; De Pol A
Cancer Lett; 2006 Sep; 241(2):203-12. PubMed ID: 16298038
[TBL] [Abstract][Full Text] [Related]
30. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
[TBL] [Abstract][Full Text] [Related]
31. The identification of monoclonality in human aberrant crypt foci.
Siu IM; Robinson DR; Schwartz S; Kung HJ; Pretlow TG; Petersen RB; Pretlow TP
Cancer Res; 1999 Jan; 59(1):63-6. PubMed ID: 9892186
[TBL] [Abstract][Full Text] [Related]
32. Role of inducible nitric oxide synthase expression in aberrant crypt foci-adenoma-carcinoma sequence.
Xu MH; Deng CS; Zhu YQ; Lin J
World J Gastroenterol; 2003 Jun; 9(6):1246-50. PubMed ID: 12800233
[TBL] [Abstract][Full Text] [Related]
33. Aberrant crypt foci in patients with colorectal cancer.
Roncucci L; Modica S; Pedroni M; Tamassia MG; Ghidoni M; Losi L; Fante R; Di Gregorio C; Manenti A; Gafa L; Ponz de Leon M
Br J Cancer; 1998 Jun; 77(12):2343-8. PubMed ID: 9649156
[TBL] [Abstract][Full Text] [Related]
34. Combinatorial chemoprevention: efficacy of lovostatin and exisulind on the formation and progression of aberrant crypt foci.
Kim KP; Whitehead C; Piazza G; Wargovich MJ
Anticancer Res; 2004; 24(3a):1805-11. PubMed ID: 15274359
[TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer.
Luo L; Shen GQ; Stiffler KA; Wang QK; Pretlow TG; Pretlow TP
Carcinogenesis; 2006 Jun; 27(6):1153-9. PubMed ID: 16474178
[TBL] [Abstract][Full Text] [Related]
36. Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans?
Gupta AK; Schoen RE
Curr Opin Gastroenterol; 2009 Jan; 25(1):59-65. PubMed ID: 19114775
[TBL] [Abstract][Full Text] [Related]
37. Methylation study of tumor suppressor genes in human aberrant crypt foci, colorectal carcinomas, and normal colon.
Sarangi J; Das P; Ahmad A; Sulaiman M; Ghosh S; Gupta B; Panwar R; Pal S; Yadav R; Ahuja V; Sen S; Upadhyay AD; Dash NR; Sharma A; Gupta SD
J Cancer Res Ther; 2024 Jan; 20(1):268-274. PubMed ID: 38554332
[TBL] [Abstract][Full Text] [Related]
38. Angiogenesis in pre-invasive cancers.
Teo NB; Shoker BS; Martin L; Sloane JP; Holcombe C
Anticancer Res; 2002; 22(4):2061-72. PubMed ID: 12174884
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of angiogenic markers in patients with seasonal allergic rhinitis.
Kirmaz C; Ozbilgin K; Yuksel H; Bayrak P; Unlu H; Giray G; Kiliccioglu B
Eur Cytokine Netw; 2004; 15(4):317-22. PubMed ID: 15627640
[TBL] [Abstract][Full Text] [Related]
40. The natural history of aberrant crypt foci.
Schoen RE; Mutch M; Rall C; Dry SM; Seligson D; Umar A; Pinsky P
Gastrointest Endosc; 2008 Jun; 67(7):1097-102. PubMed ID: 18178205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
